Literature DB >> 24049635

Sclerostin antibody: a promising treatment of osteogenesis imperfecta?

.   

Abstract

Entities:  

Year:  2012        PMID： 24049635      PMCID： PMC3727843          DOI： 10.1038/bonekey.2012.207

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN： 2047-6396


× No keyword cloud information.
  1 in total

1.  Sclerostin antibody improves skeletal parameters in a Brtl/+ mouse model of osteogenesis imperfecta.

Authors:  Benjamin P Sinder; Mary M Eddy; Michael S Ominsky; Michelle S Caird; Joan C Marini; Kenneth M Kozloff
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.